Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06932835

Comparison of Postoperative Analgesic Efficacy of Transversus Abdominis Plane Block (TAP) and Modified Thoracoabdominal Nerve Block (M-TAPA)

Laparoscopic cholecystectomy is a frequently performed surgical procedure and is considered the gold standard for treating symptomatic gallstone disease. Although laparoscopic cholecystectomy is considered minimally invasive, it can cause moderate to severe pain in the postoperative period. Poorly controlled early postoperative pain can impair recovery quality and increase the risk of postoperative pulmonary complications as a risk factor for chronic pain development. Multimodal analgesia, including opioids, is used to limit pain following laparoscopic cholecystectomy. However, opioid treatment may lead to side effects such as postoperative nausea and vomiting (PONV), respiratory depression, and constipation.

Nerve blocks provide better pain control, reduce opioid consumption in the postoperative period, and offer advantages such as fewer side effects and a lower risk of pulmonary and cardiac complications.

In our clinic, a multimodal analgesia approach is preferred for patients undergoing laparoscopic cholecystectomy. In addition to intravenous analgesic agents, peripheral nerve blocks are administered based on patient preference (for all eligible and consenting patients).

This study aims to compare the postoperative analgesic efficacy of the Transversus Abdominis Plane (TAP) Block and the Modified Thoracoabdominal Nerve Block with a Pericostal Approach (M-TAPA) in patients undergoing laparoscopic cholecystectomy. Standard analgesic methods are applied to patients who do not consent to peripheral nerve block administration.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 to 65 years old
  • American Society of Anesthesiologists (ASA) physical status I-II-III
  • Body mass index 18 to 30 kg/m2
  • Elective laparoscopic cholecystectomy surgery

Exclusion criteria

  • Under 18 and over 65
  • ASA score IV and above
  • Advanced co-morbidity
  • History of bleeding diathesis
  • Patient refusing the procedure
  • Chronic opioid or analgesic use
  • Patients who will operate under emergency conditions
  • Block injection site infection
  • Known allergy to local anesthetics
  • Pregnancy

Treatment and study plan

Transversus Abdominis Plane (TAP) Block

Drug

Transversus Abdominis Plane (TAP) Block is performed under ultrasound guidance before the surgical procedure and anesthesia induction, with the patient in the supine position.

Modified Thoracoabdominal Nerve Block (M-TAPA)

Drug

Modified Thoracoabdominal Nerve Block (M-TAPA) is performed under ultrasound guidance before the surgical procedure and anesthesia induction, with the patient in the supine position.

Primary outcomes

  1. Pain scores

    Time frame: First 24 hours after surgery

    Pain will be assessed at rest and while movement using the from 0 (no pain) to 10 (worst

Secondary outcomes

  1. Intraoperative remifentanil consumption

    Time frame: During The intraoperatif period

    The amount of remifentanil that patients need to maintain anesthesia during the intraoperative period will be recorded

Study contacts

Contact information is provided by the study sponsor or research team.

MUSA ZENGİN, Associate Professor

CONTACT

[email protected]

00905307716235

MÜRÜVVET TAŞKIR TURAN, MD

CONTACT

[email protected]

00905065536934

Sponsors and collaborators

Lead sponsor

Ankara Etlik City Hospital

Other Gov

Registry information

Official study title

Comparison of Postoperative Analgesic Efficacy of Transversus Abdominis Plane Block (TAP) and Modified Thoracoabdominal Nerve Block (M-TAPA) in Patients Undergoing Laparoscopic Cholecystectomy

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Apr 17, 2025
Registry last updated
Jun 4, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.